# A Study of AMC6156 in People With Sarcopenia

> **NCT07072195** · PHASE2 · RECRUITING · sponsor: **Animuscure Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Sarcopenia in Elderly
- Sarcopenia

## Interventions

- **DRUG:** AMC6156 0.1mg
- **DRUG:** AMC6156 0.3mg
- **DRUG:** AMC6156 1.0mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07072195
- **Lead sponsor:** Animuscure Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07072195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07072195, "A Study of AMC6156 in People With Sarcopenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07072195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*